NCT01829828

Brief Summary

The purpose of this survey is to investigate the usefulness of a patient self-reported scoring tool on patient satisfaction improvement.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
587

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 11, 2013

Completed
Last Updated

April 11, 2013

Status Verified

April 1, 2013

Enrollment Period

4 months

First QC Date

April 8, 2013

Last Update Submit

April 8, 2013

Conditions

Keywords

PainCancer painSelf-reported pain scoring toolOpioid analgesics

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction with the control of cancer-related pain

    Patients will answer on a 7-point scale how satisfied they feel about their cancer pain treatment. The scale scores range from 1 (not at all satisfied) to 7 (very much satisfied).

    At baseline

Secondary Outcomes (2)

  • Patient perception of pain

    At baseline

  • Patient pain assessment by medical staff

    At baseline

Study Arms (1)

Inpatients with cancer pain

Inpatients admitted for cancer pain management

Behavioral: No intervention

Interventions

No interventionBEHAVIORAL

This is an observational study with no investigational drug administered.

Inpatients with cancer pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inpatients admitted for cancer pain management

You may qualify if:

  • Patients who have no experience with the study self-reported pain scoring tool
  • Patients who are able to understand and answer the pain scoring tool questions
  • Patients admitted to a hospital for more than 5 days due to cancer pain
  • Patients for whom their pain managing physicians completed the medical staff's survey

You may not qualify if:

  • Patients who cannot answer the questions due to cognitive impairments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PainCancer Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Janssen Korea, Ltd., Korea Clinical Trial

    Janssen Korea, Ltd., Korea

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2013

First Posted

April 11, 2013

Study Start

January 1, 2012

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

April 11, 2013

Record last verified: 2013-04